BioSpace News Archive

H-CYTE, Inc. announced today that the Company has entered into a letter of intent to acquire SkinDisc, a patent pending tissue regeneration technology, that is expected to close within the next 30 days.

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), today announced the peer-reviewed publication of Phase IIa clinical data in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration in a paper titled, “Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS” authored by NeuroSense’s Head of Scientific Program, Dr. Shiran Zimri, and Head of ALS Program, Avital Pushett, along with leading amyotrophic lateral sclerosis (ALS) researchers.

Therapeutic Solutions International announced positive data and filing of a patent covering the use of CampbellCell for treatment of Bipolar Disorder by the Company’s suicide prevention based spin-off Campbell Neurosciences.

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will convene a panel titled “Clinical Genomics Is Now. Are You Ready?” at its inaugural Illumina Genomics Forum (IGF), moderated by Nobel laureate and chemical engineer Frances Arnold of the California Institute of Technology.

RxCap, Inc., cloud-based remote monitoring enablement company, and ZEPHYRx LLC, a remote respiratory monitoring solutions provider, announced that they have entered into a partnership to integrate the ZEPHYRx cloud spirometry platform with RxCap’s remote monitoring platform.

BIOQUAL Presents Financial Results for Fiscal Year 2022.

Vascular screening is otherwise called non-intrusive vascular testing in which different innovation based gadgets are used to assess the veins. The assessment and testing of the veins can be done at the rest time or at the hour of the activity.

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today filing of a provisional patent application with the USPTO entitled “Dual Checkpoint Inhibitor Aptamer Based Therapeutics”.

The latest market analysis report published by Reports and Data, titled ‘Global Diabetic Foot Ulcer Market – Forecast to 2030,’ thoroughly examines the Diabetic Foot Ulcer industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Pagets Disease Treatment Market – Forecast to 2030,’ thoroughly examines the Pagets Disease Treatment industry to provide essential data & information for the targeted readers.